Literature DB >> 26864248

Usual interstitial pneumonia in asbestos-exposed cohorts - concurrent idiopathic pulmonary fibrosis or atypical asbestosis?

Richard L Attanoos1, Fouad S Alchami1, Frederick D Pooley2, Allen R Gibbs1.   

Abstract

AIMS: To determine whether usual interstitial pneumonia (UIP) pattern fibrosis is seen in asbestosis. METHODS AND
RESULTS: The occurrence of UIP pattern fibrosis was studied in four asbestos cohorts systematically referred following postmortem to the UK Pneumoconiosis Unit, Cardiff. The combined exposed workforce comprised >25 000 persons. Over the 17-year period, 233 subjects were identified; 210 had degrees of interstitial fibrosis with a fibrotic non-specific interstitial pneumonia pattern and subpleural accentuation, and three showed UIP pattern fibrosis. All three of these cases showed grade 4 fibrosis (honeycombing) with no asbestos fibre dose-response correlation. A Poisson distribution of probability analysis indicated that the observed cases of UIP in this workforce could be wholly accounted for by the prevalence of idiopathic pulmonary fibrosis (IPF) in the population.
CONCLUSIONS: UIP pattern fibrosis is rarely observed in asbestos-exposed subjects, and shows no dose-response correlation with asbestos fibres on mineral analysis; this points to an alternative disease, such as IPF. The results indicate that UIP pattern fibrosis should not be regarded as genuine asbestosis, irrespective of the status of asbestos biomarkers, and this impacts upon the postmortem handling of asbestos-related deaths.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  asbestos; asbestosis; usual interstitial pneumonia

Mesh:

Year:  2016        PMID: 26864248     DOI: 10.1111/his.12951

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

Review 1.  [The German Mesothelioma Register : Current pathological diagnostics and services].

Authors:  I S Feder; M Jülich; A Tannapfel; I Tischoff
Journal:  Pathologe       Date:  2018-12       Impact factor: 1.011

2.  Comparison between the ATS/ERS/JRS/ALAT criteria of 2011 and 2018 for Usual Interstitial Pneumonia on HRCT: a cross-sectional study.

Authors:  Laura L Wuyts; Michael Camerlinck; Didier De Surgeloose; Liesbet Vermeiren; David Ceulemans; Johan Clukers; Hans Slabbynck
Journal:  Br J Radiol       Date:  2021-02-04       Impact factor: 3.039

3.  The asbestos fibre burden in human lungs: new insights into the chrysotile debate.

Authors:  Inke Sabine Feder; Iris Tischoff; Anja Theile; Inge Schmitz; Rolf Merget; Andrea Tannapfel
Journal:  Eur Respir J       Date:  2017-06-29       Impact factor: 16.671

4.  Idiopathic pulmonary fibrosis and occupational risk factors.

Authors:  Silvia Ranzieri; Elisa Illica Magrini; Paola Mozzoni; Roberta Andreoli; Giovanna Pelà; Giuseppina Bertorelli; Massimo Corradi
Journal:  Med Lav       Date:  2019-12-17       Impact factor: 1.275

5.  Reply to Sanyal et al.: Overlooked Role of Histopathology in Evaluations for Occupational/Environmental Exposures.

Authors:  Daniel A Culver; Sanjay Mukhopadhyay; Jurgen Behr; Hyun Kim
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

Review 6.  Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis.

Authors:  Myriam Aburto; Inmaculada Herráez; David Iturbe; Ana Jiménez-Romero
Journal:  Med Sci (Basel)       Date:  2018-09-04

7.  Tirbanibulin Attenuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling.

Authors:  Xin Wang; Rui Ren; Zehui Xu; Haidi Huang; Wanglin Jiang; Jinbo Ma
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

Review 8.  Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.

Authors:  Willis S Bowman; Gabrielle A Echt; Justin M Oldham
Journal:  Front Med (Lausanne)       Date:  2021-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.